They were first developed to treat type 2 diabetes, but millions of people now use them for weight loss, too
References: A Brave New World: Therapeutic Area Deep Dives on Obesity This blog is part of a new series exploring a range of topics in the obesity market, including: market size and scope, impact of payer controls, activity in non-traditional channels, patient behavior, GLP-1 impact, HCP responses, the policy landscape, pharmacy economics, and the outlook for the future of GLP-1
The problem is discontinuation rates are sky-high: 36-81% of patients quit
Ze zitten in groente, fruit en volkorenproducten" Tijdens en na het gebruik van GLP-1-receptoragonisten is het belangrijk om ervoor te zorgen dat u geen voedingsstoffen tekortkomt en een blijvende verandering teweeg brengt in uw voedingspatroon en in uw leefwijze
Semaglutide and tirzepatide are long-term therapies running 12 to 52+ weeks
El evento adverso ms comnmente informado fue nuseas